New cancer drug trial aims to boost Chemo's power
Disease control
Recruiting now
This study is testing whether adding a new drug called BOLD-100 to standard FOLFOX chemotherapy can better control advanced cancers of the colon, pancreas, stomach, and bile ducts. Researchers will first find the safest dose of BOLD-100 and then see if the combination helps slow …
Phase: PHASE1, PHASE2 • Sponsor: Bold Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC